Home > Companies > Pharma Dynamics (Pty) Ltd

Pharma Dynamics (Pty) Ltd

pharmadynamics.co.za

Pharma Dynamics is the country’s leader in cardiovascular medication since 2012 - both in terms of value and volume – and is the fastest growing generic pharmaceutical company in South Africa. The organisation celebrates 16 years of improving the quality of life for South Africans after entrenching its mark in the industry with the launch of Amloc and Bilocor – SA’s two top selling anti-hypertensives. Today, Pharma Dynamics is active in more than 27 therapeutic areas, which include Central Nervous System (CNS), Female Healthcare, antimicrobial, pain and GIT categories, and it also supplies a range of Over the Counter (OTC) products.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

National Medtech & Biotech Summit 2024

Conference

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

Conference

Related News

Practice Management

APRECIA ANNOUNCES NEW LEADERSHIP TEAM

Aprecia Pharmaceuticals | October 21, 2021

Kyle Smith has been named President and Chief Operating Officer of Aprecia Pharmaceuticals, LLC, effective immediately. Mr. Smith is a 10-year veteran with Aprecia and has served as Vice President of Operations for the past 3 years. As President and Chief Operating Officer, Mr. Smith will be responsible for leading day-to-day business activities. Aprecia has further strengthened its leadership team by promoting Patrick Staudt to Vice President of Operations, effective immediately....

Business Insights, PHARMA TECH

ENDO ANNOUNCES AGREEMENT WITH SLAYBACK PHARMA TO DISTRIBUTE PREVDUO™ THE FIRST AND ONLY FDA-APPROVED NEOSTIGMINE-GLYCOPYRROLATE COMBINATION

prnewswire | April 28, 2023

Endo International plc announced that its subsidiaries Endo Ventures Limited and Par Pharmaceutical, Inc. have executed an agreement with Slayback Pharma LLC to distribute Slayback's Prevduo™ (neostigmine methylsulfate and glycopyrrolate injection) pre-filled syringe on an exclusive basis in the U.S. The U.S. Food and Drug Administration (FDA) approved Prevduo™ in February 2023 for the reversal of the effects of nondepolarizing neuromuscular blocking agents (NMBA) after sur...

Business Insights

EYEPOINT PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

EyePoint Pharmaceuticals, Inc. | April 19, 2022

EyePoint Pharmaceuticals, Inc. a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2016 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 56,500 shares of EyePoint Ph...

GILEAD JOINS GSK, J&J IN OFFERING CORONAVIRUS VACCINE OPTIONS

PharmaTimes | February 05, 2020

With the death toll in China topping 425, the coronavirus, now officially classified as a global health threat by the World Health Organisation (WHO), is showing no signs of slowing down. More than 20,000 cases have been confirmed around the world, with more than 20 nations reporting cases – some involving locals who had not even travelled to China. The pharma industry has been rallying together in a joint effort to develop a vaccine for the virus, which is also known as 2019-nCoV or Wuhan...

Practice Management